Quarterly report · Q1
2370.TEDINET S100SUKD
Period2023-10-01 → 2023-12-31
Filed2024-02-13
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 32
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥248m | 2023-10-01 → 2023-12-31 | Standalone | Net sales |
| Revenue | ¥662m | 2022-10-01 → 2023-09-30 | Standalone | Net sales (5-year summary) |
| Revenue | ¥185m | 2022-10-01 → 2022-12-31 | Standalone | Net sales |
| Operating income | −¥294m | 2023-10-01 → 2023-12-31 | Standalone | Operating income |
| Operating income | −¥325m | 2022-10-01 → 2022-12-31 | Standalone | Operating income |
| Ordinary income | −¥292m | 2023-10-01 → 2023-12-31 | Standalone | Ordinary income |
| Ordinary income | −¥1.4bn | 2022-10-01 → 2023-09-30 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥324m | 2022-10-01 → 2022-12-31 | Standalone | Ordinary income |
| Profit before tax | −¥292m | 2023-10-01 → 2023-12-31 | Standalone | Income before income taxes |
| Profit before tax | −¥324m | 2022-10-01 → 2022-12-31 | Standalone | Income before income taxes |
| Net income | −¥293m | 2023-10-01 → 2023-12-31 | Standalone | Profit loss |
| Net income | −¥1.4bn | 2022-10-01 → 2023-09-30 | Standalone | Net income loss (5-year summary) |
| Net income | −¥326m | 2022-10-01 → 2022-12-31 | Standalone | Profit loss |
| Total assets | ¥6.3bn | at 2023-12-31 | Standalone | Assets |
| Total assets | ¥5.6bn | at 2023-09-30 | Standalone | Assets |
| Total assets | ¥5.5bn | at 2022-12-31 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥549m | at 2023-12-31 | Standalone | Liabilities |
| Total liabilities | ¥590m | at 2023-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥5.8bn | at 2023-12-31 | Standalone | Net assets |
| Net assets / equity | ¥5.0bn | at 2023-09-30 | Standalone | Net assets |
| Net assets / equity | ¥5.0bn | at 2022-12-31 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥5.0bn | at 2023-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥4.4bn | at 2023-09-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥-1.2 | 2023-10-01 → 2023-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-6.65 | 2022-10-01 → 2023-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-1.54 | 2022-10-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 91.3% | at 2023-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.2% | at 2023-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.8% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 253,510,757 | at 2023-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 232,160,757 | at 2023-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 211,730,423 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2023-12-31 | −¥147m |
| jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue | 2023-10-01 → 2023-12-31 | ¥56,000 |
| jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue external | 2023-10-01 → 2023-12-31 | ¥56,000 |
| jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segment | segment profit | 2023-10-01 → 2023-12-31 | −¥115m |
| jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue | 2023-10-01 → 2023-12-31 | ¥248m |
| jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue external | 2023-10-01 → 2023-12-31 | ¥248m |
| jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segment | segment profit | 2023-10-01 → 2023-12-31 | −¥32m |
| —segment total | revenue | 2023-10-01 → 2023-12-31 | ¥248m |
| —segment total | revenue external | 2023-10-01 → 2023-12-31 | ¥248m |
| —segment total | segment profit | 2023-10-01 → 2023-12-31 | −¥147m |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2022-12-31 | −¥161m |
| jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥158,000 |
| jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥158,000 |
| jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segment | segment profit | 2022-10-01 → 2022-12-31 | −¥107m |
| jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥185m |
| jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥185m |
| jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segment | segment profit | 2022-10-01 → 2022-12-31 | −¥57m |
| —segment total | revenue | 2022-10-01 → 2022-12-31 | ¥185m |
| —segment total | revenue external | 2022-10-01 → 2022-12-31 | ¥185m |
| —segment total | segment profit | 2022-10-01 → 2022-12-31 | −¥164m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 307
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report non consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)普 賢 監 査 法 人 | |
| Cpa1 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)佐 藤 功 一 | |
| Cpa2 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)髙 橋 弘 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | 185153000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | 248236000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 661543000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | -324481000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | -291981000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration_NonConsolidatedMember | -1419182000 | JPY |
| Net income loss (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | -325521000 | JPY |
| Net income loss (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | -292637000 | JPY |
| Net income loss (5-year summary) | Prior1YearDuration_NonConsolidatedMember | -1437950000 | JPY |
| Equity in earnings losses of affiliates if equity method is applied (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | － | JPY |
| Equity in earnings losses of affiliates if equity method is applied (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | － | JPY |
| Equity in earnings losses of affiliates if equity method is applied (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | JPY |
| Capital stock (5-year summary) | Prior1QuarterInstant_NonConsolidatedMember | 5892020000 | JPY |
| Capital stock (5-year summary) | CurrentQuarterInstant_NonConsolidatedMember | 6238555000 | JPY |
| Capital stock (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 5736788000 | JPY |
| Total number of issued shares (5-year summary) | Prior1QuarterInstant_NonConsolidatedMember | 211730423 | |
| Total number of issued shares (5-year summary) | CurrentQuarterInstant_NonConsolidatedMember | 253510757 | |
| Total number of issued shares (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 232160757 | |
| Net assets (5-year summary) | Prior1QuarterInstant_NonConsolidatedMember | 5042549000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant_NonConsolidatedMember | 5800050000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 5043941000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant_NonConsolidatedMember | 5490901000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant_NonConsolidatedMember | 6348677000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 5634145000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | -1.54 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | -1.20 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | -6.65 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | |
| Dividend paid per share (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | － | |
| Dividend paid per share (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | － | |
| Dividend paid per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant_NonConsolidatedMember | 0.918 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant_NonConsolidatedMember | 0.913 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 0.892 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 253510757 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 253690306 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 253510757 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 253690306 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithFullVotingRightsTreasurySharesEtcMember | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |